These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 994932)

  • 61. Endoscopic thoracic sympathicotomy for Raynaud's phenomenon.
    Matsumoto Y; Ueyama T; Endo M; Sasaki H; Kasashima F; Abe Y; Kosugi I
    J Vasc Surg; 2002 Jul; 36(1):57-61. PubMed ID: 12096258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
    Anderson JE; Held N; Wright K
    Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
    Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
    J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enalapril in Raynaud's phenomenon.
    Janini SD; Scott DG; Coppock JS; Bacon PA; Kendall MJ
    J Clin Pharm Ther; 1988 Apr; 13(2):145-50. PubMed ID: 2839529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.
    WINTERBAUER RH
    Bull Johns Hopkins Hosp; 1964 Jun; 114():361-83. PubMed ID: 14171636
    [No Abstract]   [Full Text] [Related]  

  • 66. Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series.
    Dhaliwal K; Griffin MF; Salinas S; Howell K; Denton CP; Butler PEM
    Clin Rheumatol; 2019 Dec; 38(12):3669-3676. PubMed ID: 31482318
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Idiopathic calcific pancreatitis, CRST syndrome and progressive systemic sclerosis.
    Greif JM; Wolff WI
    Am J Gastroenterol; 1979 Feb; 71(2):177-82. PubMed ID: 433900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathogenesis and treatment of Raynaud's phenomenon.
    Coffman JD
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():45-51. PubMed ID: 2285650
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The clinical significance of Raynaud's syndrome.
    Porter JM; Bardana EJ; Baur GM; Wesche DH; Andrasch RH; Rösch J
    Surgery; 1976 Dec; 80(6):756-64. PubMed ID: 1006524
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Neumeister MW
    J Hand Surg Am; 2010 Dec; 35(12):2085-92. PubMed ID: 21134617
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine].
    Zicot M
    Rev Med Liege; 1980 Oct; 35(19):652-4. PubMed ID: 6161403
    [No Abstract]   [Full Text] [Related]  

  • 72. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenon.
    Tschöpe C; Westermann D; Steendijk P; Kasner M; Rudwaleit M; Schwimmbeck PL; Poller WC; Schultheiss HP
    Clin Res Cardiol; 2006 Jun; 95(6):344-8. PubMed ID: 16741592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of patients with secondary Raynaud's syndrome.
    Ehrly AM
    Acta Chir Scand Suppl; 1976; 465():92-5. PubMed ID: 1069443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome.
    Reynolds TB; Denison EK; Frankl HD; Lieberman FL; Peters RL
    Am J Med; 1971 Mar; 50(3):302-12. PubMed ID: 5553949
    [No Abstract]   [Full Text] [Related]  

  • 76. Does prevalence of migraine and Raynaud's phenomenon also increase in Korean patients with proven variant angina?
    Koh KK; Kim SH; Lee KH; Kwon KS; Kim EJ; Baik SH; Cho SK; Kim SS; Park CO; Chung JK
    Int J Cardiol; 1995 Aug; 51(1):37-46. PubMed ID: 8522395
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Scleroderma and primary biliary cirrhosis.
    Murray-Lyon IM; Thompson RP; Ansell ID; Williams R
    Br Med J; 1970 Aug; 3(5717):258-9. PubMed ID: 5448799
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
    J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dystrophic calcification in muscles of legs in calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia syndrome: Accurate evaluation of the extent with (99m)Tc-methylene diphosphonate single photon emission computed tomography/computed tomography.
    Chakraborty PS; Karunanithi S; Dhull VS; Kumar K; Tripathi M
    Indian J Nucl Med; 2015; 30(4):360-1. PubMed ID: 26430328
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.